Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency

Penelope E. Graves, Paul E Fenster, Ronald T. MacFarland, Frank I. Marcus, Donald Perrier

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The kinetics of digitoxin and two of its major metabolites, the bis- and monodigitoxosides of digitoxigenin, were determined in six subjects with renal insufficiency and compared to those in six age- and sex-matched normal control subjects. No significant differences between the two groups were found in elimination t 1 2, total body clearance, or volume of distribution. Average renal clearances of all three drugs were reduced in subjects with renal failure, but the differences were significant only in the case of digitoxin. The bis-digitoxoside of digitoxigenin has kinetic properties that offer clinical advantages.

Original languageEnglish (US)
Pages (from-to)607-612
Number of pages6
JournalClinical Pharmacology and Therapeutics
Volume36
Issue number5
StatePublished - Nov 1984

Fingerprint

Digitoxin
Renal Insufficiency
Kidney
Pharmaceutical Preparations
digitoxigenin monodigitoxoside
digitoxigenin-bis(digitoxoside)

ASJC Scopus subject areas

  • Pharmacology

Cite this

Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency. / Graves, Penelope E.; Fenster, Paul E; MacFarland, Ronald T.; Marcus, Frank I.; Perrier, Donald.

In: Clinical Pharmacology and Therapeutics, Vol. 36, No. 5, 11.1984, p. 607-612.

Research output: Contribution to journalArticle

Graves, Penelope E. ; Fenster, Paul E ; MacFarland, Ronald T. ; Marcus, Frank I. ; Perrier, Donald. / Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency. In: Clinical Pharmacology and Therapeutics. 1984 ; Vol. 36, No. 5. pp. 607-612.
@article{08ce159096874146aec0442d4bab1441,
title = "Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency",
abstract = "The kinetics of digitoxin and two of its major metabolites, the bis- and monodigitoxosides of digitoxigenin, were determined in six subjects with renal insufficiency and compared to those in six age- and sex-matched normal control subjects. No significant differences between the two groups were found in elimination t 1 2, total body clearance, or volume of distribution. Average renal clearances of all three drugs were reduced in subjects with renal failure, but the differences were significant only in the case of digitoxin. The bis-digitoxoside of digitoxigenin has kinetic properties that offer clinical advantages.",
author = "Graves, {Penelope E.} and Fenster, {Paul E} and MacFarland, {Ronald T.} and Marcus, {Frank I.} and Donald Perrier",
year = "1984",
month = "11",
language = "English (US)",
volume = "36",
pages = "607--612",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency

AU - Graves, Penelope E.

AU - Fenster, Paul E

AU - MacFarland, Ronald T.

AU - Marcus, Frank I.

AU - Perrier, Donald

PY - 1984/11

Y1 - 1984/11

N2 - The kinetics of digitoxin and two of its major metabolites, the bis- and monodigitoxosides of digitoxigenin, were determined in six subjects with renal insufficiency and compared to those in six age- and sex-matched normal control subjects. No significant differences between the two groups were found in elimination t 1 2, total body clearance, or volume of distribution. Average renal clearances of all three drugs were reduced in subjects with renal failure, but the differences were significant only in the case of digitoxin. The bis-digitoxoside of digitoxigenin has kinetic properties that offer clinical advantages.

AB - The kinetics of digitoxin and two of its major metabolites, the bis- and monodigitoxosides of digitoxigenin, were determined in six subjects with renal insufficiency and compared to those in six age- and sex-matched normal control subjects. No significant differences between the two groups were found in elimination t 1 2, total body clearance, or volume of distribution. Average renal clearances of all three drugs were reduced in subjects with renal failure, but the differences were significant only in the case of digitoxin. The bis-digitoxoside of digitoxigenin has kinetic properties that offer clinical advantages.

UR - http://www.scopus.com/inward/record.url?scp=0021686487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021686487&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 607

EP - 612

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 5

ER -